Human Papillomavirus and Prognosis of Oropharyngeal Squamous Cell Carcinoma: Implications for Clinical Research in Head and Neck Cancers
about
Predictive value of epigenetic alterations in head and neck squamous cell carcinomaDetection of HPV infection in head and neck squamous cell carcinoma: a practical proposalHPV infection and EGFR activation/alteration in HIV-infected East African patients with conjunctival carcinomaAdvances and Perspectives in the Molecular Diagnosis of Head and Neck Cancer.Human Papilloma Virus (HPV) in head and neck region: review of literature.HUMAN PAPILLOMAVIRUS ASSOCIATION WITH HEAD AND NECK CANCERS: UNDERSTANDING VIRUS BIOLOGY AND USING IT IN THE DEVELOPMENT OF CANCER DIAGNOSTICSHuman papillomavirus-mediated carcinogenesis and HPV-associated oral and oropharyngeal squamous cell carcinoma. Part 2: Human papillomavirus associated oral and oropharyngeal squamous cell carcinomap16(INK4A) immunohistochemical staining may be helpful in distinguishing branchial cleft cysts from cystic squamous cell carcinomas originating in the oropharynx.The relationship between oral squamous cell carcinoma and human papillomavirus: a meta-analysis of a Chinese population (1994-2011).Malignant and noninvasive skin tumours in renal transplant recipientsDifferential impact of IL-10 expression on survival and relapse between HPV16-positive and -negative oral squamous cell carcinomas.Human papilloma virus in head and neck squamous cell cancer.NDN and CD1A are novel prognostic methylation markers in patients with head and neck squamous carcinomas.Activation of MET pathway predicts poor outcome to cetuximab in patients with recurrent or metastatic head and neck cancerCompeting causes of death in patients with oropharyngeal cancer treated with radiotherapy.Selective participation of c-Jun with Fra-2/c-Fos promotes aggressive tumor phenotypes and poor prognosis in tongue cancer.HPV-related oropharyngeal carcinoma with Overt Level II and/or III metastases at presentation: The risk of subclinical disease in ipsilateral levels IB, IV and V.E6 viral protein ratio correlates with outcomes in human papillomavirus related oropharyngeal cancer.HPV Prevalence and Prognostic Value in a Prospective Cohort of 255 Patients with Locally Advanced HNSCC: A Single-Centre Experience.Volumetric change of human papillomavirus-related neck lymph nodes before, during, and shortly after intensity-modulated radiation therapy.Recurrent head and neck cancer: current treatment and future prospects.Molecular Signature of HPV-Induced Carcinogenesis: pRb, p53 and Gene Expression Profiling.PD-L1 expression in tonsillar cancer is associated with human papillomavirus positivity and improved survival: implications for anti-PD1 clinical trials.Human papillomavirus-mediated carcinogenesis and HPV-associated oral and oropharyngeal squamous cell carcinoma. Part 1: human papillomavirus-mediated carcinogenesis.Epigenetic and genetic alterations-based molecular classification of head and neck cancer.Etiologic factors associated with oral squamous cell carcinoma in non-smokers and non-alcoholic drinkers: a brief approach.Human papillomavirus-related cell cycle markers can predict survival outcomes following a transoral lateral oropharyngectomy for tonsillar squamous cell carcinoma.Smokeless tobacco increases aneuploidy in oral HPV16 E6/E7-transformed keratinocytes in vitro.Impact of p16, p53, smoking, and alcohol on survival in patients with oropharyngeal squamous cell carcinoma treated with primary intensity-modulated chemoradiation.Rising population of survivors of oral squamous cell cancer in the United States.Ki67 Expression has Prognostic Significance in Relation to Human Papillomavirus Status in Oropharyngeal Squamous Cell Carcinoma.Stability of methylation markers in head and neck squamous cell carcinoma.Prognostic value of p16 expression irrespective of human papillomavirus status in patients with oropharyngeal carcinoma.TriCurin, a novel formulation of curcumin, epicatechin gallate, and resveratrol, inhibits the tumorigenicity of human papillomavirus-positive head and neck squamous cell carcinoma.The E8--E2 gene product of human papillomavirus type 16 represses early transcription and replication but is dispensable for viral plasmid persistence in keratinocytes.Human papilloma virus and survival of oropharyngeal cancer patients treated with surgery and adjuvant radiotherapy.Phospho-Rb (Ser780) as a biomarker in patients with cervical lymph node metastases from an unknown primary tumour: a retrospective cohort study.Use of cyclin D1 in conjunction with human papillomavirus status to predict outcome in oropharyngeal cancer.Prognostic value of p16 expression and alcohol consumption in Japanese patients with oropharyngeal squamous cell carcinoma.Quality of life of oropharyngeal cancer patients with respect to treatment strategy and p16-positivity.
P2860
Q27690755-F17FE795-1EC8-4103-9DA8-F89EE8703C2CQ28287388-59668B52-F660-4694-8641-AFCE4147A620Q33586269-9A925419-B4DE-4A1E-B18E-4E2CF265E6BBQ33610394-6723377F-5B03-4DEF-B756-065EB3BD6785Q33626377-5EC91BDA-E718-4ABF-B22B-9D62A8FEBB08Q33805498-712ADA0B-0C39-48D0-853A-2D7EF1AA6EC8Q34049591-D6647280-0416-4E09-80FF-BEFD09AD8324Q34102573-572E578D-05AD-4691-B1C1-CF81E70A0944Q34263251-F9679722-782B-440D-B179-214FEFF377B2Q34268585-C29A7C2B-9755-4262-8523-067F8DEFF74BQ34464484-4802AC99-BAAD-40A8-A52F-4112E957ABE4Q35156197-0CC782EF-104E-443F-AF9A-FC8D7E13F48DQ35827866-5B895524-A15E-4221-9993-D9E5B0E54D01Q36005545-FA1A27FC-0F5D-43B5-89D4-5B289D00B9F4Q36224590-C4FBE2DD-918B-48B3-9D2E-E2DB15A65946Q36297882-3EE5759F-B2BD-40CC-8F13-DCD498376E9CQ36416456-37278ABF-9359-4BC2-A382-FDF5B8F1748BQ36844328-25AB2D37-5F34-452E-8DD8-E8A8D863ED16Q36848497-432C33A8-6F8D-416E-8085-BF8B01927E7BQ37023773-9FF73BB1-4196-467B-8975-C3AA4C57B66AQ37118936-E169EEC8-F62C-469A-9B32-E8322073DE02Q37236208-44D8239B-873C-445C-9299-4C1E793E105CQ37718331-302C9AC3-3796-4010-AB73-6BE49576D2E3Q37772990-653B6944-B610-4060-BA04-09163C9F3175Q37999072-8A724527-E462-4226-B1E9-E5C08C807B43Q38073066-09555F46-A1A1-44EB-B80C-C00DE217BD95Q38437573-AFED5C56-5BB3-4DFE-95F8-9086AF44FB4DQ39001531-00B7316E-E25C-4BA3-B543-FA028A042E05Q39448913-9A4D20A4-F708-4292-B88A-0F2184CB8AC0Q39942022-A22E67A9-6EB9-4057-939C-C4E88BBEFA6AQ41657808-0B57D42D-2301-4403-8063-2313D967169EQ41659557-3184B790-1EF6-4BC2-97A1-7ADF1E550692Q41684875-986BCBF5-FA96-4044-8DB1-2A9D3B9C6FBDQ41694370-A7AFE201-9294-4133-904D-77E63D7328A3Q41994813-0232F709-845A-42E5-9690-3CF18B56046DQ42215642-33FB3297-A6AC-4594-B9BF-9BE944240B9EQ43551301-88416826-6BD4-40A7-836E-C191A75F209DQ43689874-D9918479-C272-4972-B574-40A8D5A639F9Q44645654-50BE64D7-15E4-4A4A-9FF8-54679060C39BQ45346918-E16F6455-EDCC-47CC-B7A1-57551F1B753F
P2860
Human Papillomavirus and Prognosis of Oropharyngeal Squamous Cell Carcinoma: Implications for Clinical Research in Head and Neck Cancers
description
2006 nî lūn-bûn
@nan
2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Human Papillomavirus and Progn ...... earch in Head and Neck Cancers
@ast
Human Papillomavirus and Progn ...... earch in Head and Neck Cancers
@en
Human Papillomavirus and Progn ...... earch in Head and Neck Cancers
@en-gb
Human Papillomavirus and Progn ...... earch in Head and Neck Cancers
@nl
type
label
Human Papillomavirus and Progn ...... earch in Head and Neck Cancers
@ast
Human Papillomavirus and Progn ...... earch in Head and Neck Cancers
@en
Human Papillomavirus and Progn ...... earch in Head and Neck Cancers
@en-gb
Human Papillomavirus and Progn ...... earch in Head and Neck Cancers
@nl
altLabel
Human papillomavirus and progn ...... earch in head and neck cancers
@en
prefLabel
Human Papillomavirus and Progn ...... earch in Head and Neck Cancers
@ast
Human Papillomavirus and Progn ...... earch in Head and Neck Cancers
@en
Human Papillomavirus and Progn ...... earch in Head and Neck Cancers
@en-gb
Human Papillomavirus and Progn ...... earch in Head and Neck Cancers
@nl
P356
P1476
Human Papillomavirus and Progn ...... earch in Head and Neck Cancers
@en
P2093
M. L. Gillison
P304
P356
10.1200/JCO.2006.07.1829
P407
P577
2006-12-20T00:00:00Z